A Synthetic SARS-CoV-2-Derived T-Cell and B-Cell Peptide Cocktail Elicits Full Protection against Lethal Omicron BA.1 Infection in H11-K18-hACE2 Mice
Yang Song(National Institute for Viral Disease Control and Prevention), Wenbo Xu(Shenyang Institute of Automation), Baicheng Xia(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongqiao Hu(National Institute for Viral Disease Control and Prevention), Jiannan Zhao(Chinese Academy of Agricultural Sciences), Tianjiao Ji(National Health and Family Planning Commission), Lei Cao(Chinese Academy of Sciences), Yong Zhang(Hebei Medical University), Yan Zhang(Memorial Sloan Kettering Cancer Center), Hongxia Guo(National Institute for Viral Disease Control and Prevention), Jie Jiang(Taiwan Centers for Disease Control), Kang Xiao(National Institute for Viral Disease Control and Prevention), Xinghu Huang(National Institute for Viral Disease Control and Prevention), Shuangli Zhu(Chinese Center For Disease Control and Prevention), Yuqing Shi(National Institute for Viral Disease Control and Prevention)
Cited by 5
Related Papers
A Novel Coronavirus from Patients with Pneumonia in China, 2019
|New England Journal of Medicine|2020|30.5k
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
|The Lancet|2020|12.6k
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
|Nature|2020|1.2k